136 related articles for article (PubMed ID: 3163714)
21. [Analysis of serum CA125, CEA, AFP, LDH levels and LDH isoenzymes in patients with ovarian tumors--correlation between tumor markers and histological types of ovarian tumors].
Konishi I; Fujii S; Okamura H; Sakahara H; Endo K; Torizuka K; Suzuki A; Mori T
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):827-36. PubMed ID: 2426374
[TBL] [Abstract][Full Text] [Related]
22. Mucin expression in nonneoplastic and neoplastic glandular epithelia of the uterine cervix.
Zhao S; Hayasaka T; Osakabe M; Kato N; Nakahara K; Kurachi H; Fukase M; Katayama Y; Yaegashi N; Motoyama T
Int J Gynecol Pathol; 2003 Oct; 22(4):393-7. PubMed ID: 14501822
[TBL] [Abstract][Full Text] [Related]
23. An immunohistochemical study of difference between cervical and endometrial adenocarcinomas of the uterus--using monoclonal antibodies of CEA and cytokeratin.
Jinnouchi H
Fukushima J Med Sci; 1987 Jun; 33(1):29-46. PubMed ID: 2459040
[No Abstract] [Full Text] [Related]
24. Immunohistochemical localization of carcinoembryonic antigen in adenocarcinoma of the endocervix and the endometrium.
Toki T; Oikawa N; Tase T; Wada Y; Yajima A; Suzuki M
Tohoku J Exp Med; 1985 May; 146(1):27-32. PubMed ID: 3895576
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical studies on carcinoembryonic antigen in adenocarcinomas of the uterus.
Ueda S; Tsubura A; Izumi H; Sasaki M; Morii S
Acta Pathol Jpn; 1983 Jan; 33(1):59-69. PubMed ID: 6340419
[TBL] [Abstract][Full Text] [Related]
26. [Immunohistochemical investigation of vimentin of uterine endometrial and endocervical adenocarcinoma].
Ohwada M; Suzuki M; Tamada T
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Sep; 42(9):1237-43. PubMed ID: 2212824
[TBL] [Abstract][Full Text] [Related]
27. [Mucohistochemical studies of CEA producing and non-producing stomach cancers].
Iguchi K; Tanaka T; Yamagishi H; Inaba S; Fujimori C; Kurioka H; Kobayashi M; Hashimoto I
Gan No Rinsho; 1983 Aug; 29(9):971-80. PubMed ID: 6194317
[TBL] [Abstract][Full Text] [Related]
28. Minimal deviation adenocarcinoma of the uterine cervix has abnormal expression of sex steroid receptors, CA125, and gastric mucin.
Toki T; Shiozawa T; Hosaka N; Ishii K; Nikaido T; Fujii S
Int J Gynecol Pathol; 1997 Apr; 16(2):111-6. PubMed ID: 9100063
[TBL] [Abstract][Full Text] [Related]
29. Re-classification of carcinoma cervix uteri by mucin histochemistry.
Misra V; Gupta SC; Goel A; Singh PA
Indian J Pathol Microbiol; 1997 Oct; 40(4):463-8. PubMed ID: 9444856
[TBL] [Abstract][Full Text] [Related]
30. Cervical adenocarcinomas express markers common to gastric, intestinal, and pancreatobiliary epithelial cells.
Tenti P; Romagnoli S; Silini E; Zappatore R; Giunta P; Stella G; Carnevali L
Pathol Res Pract; 1994 Apr; 190(4):342-9. PubMed ID: 8078803
[TBL] [Abstract][Full Text] [Related]
31. Utility of the monoclonal antibody HIK1083 in the diagnosis of adenoma malignum of the uterine cervix.
Utsugi K; Hirai Y; Takeshima N; Akiyama F; Sakurai S; Hasumi K
Gynecol Oncol; 1999 Dec; 75(3):345-8. PubMed ID: 10600287
[TBL] [Abstract][Full Text] [Related]
32. Cervical adenocarcinoma: a retrospective clinicopathologic study of 16 cases.
Barbu I; Crăiţoiu S; Mărgăritescu C
Rom J Morphol Embryol; 2012; 53(3):615-24. PubMed ID: 22990556
[TBL] [Abstract][Full Text] [Related]
33. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
[TBL] [Abstract][Full Text] [Related]
34. Alterations in mucin type: an indicator for suspicion of malignant gastric transformation.
Cheah PL; Ramachandran K
Malays J Pathol; 1994 Jun; 16(1):39-42. PubMed ID: 16329574
[TBL] [Abstract][Full Text] [Related]
35. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
36. [Clinicopathological, ultrastructural and immunohistochemical study on adenoma malignum of the uterine cervix].
Yamagata S; Yamamoto K; Tsuchida S; Kawamura N; Nakamura T; Sugawa T
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jan; 43(1):57-64. PubMed ID: 1997616
[TBL] [Abstract][Full Text] [Related]
37. Clinical value of CA125, CA19-9, CEA, CA72-4, and TPA in borderline ovarian tumor.
Tamakoshi K; Kikkawa F; Shibata K; Tomoda K; Obata NH; Wakahara F; Tokuhashi Y; Ishikawa H; Kawai M; Tomoda Y
Gynecol Oncol; 1996 Jul; 62(1):67-72. PubMed ID: 8690294
[TBL] [Abstract][Full Text] [Related]
38. Reappraisal of orthodox histochemistry for the diagnosis of minimal deviation adenocarcinoma of the cervix.
Hayashi I; Tsuda H; Shimoda T
Am J Surg Pathol; 2000 Apr; 24(4):559-62. PubMed ID: 10757403
[TBL] [Abstract][Full Text] [Related]
39. [An autopsy case of a gastric cancer associated with elevated AFP, CEA and CA19-9].
Nakamura Y; Hozumi T; Ohkita M; Masuda S; Maeda M; Okada K; Chinzei T; Yamashiro K; Harui M; Hosokawa I
Gan No Rinsho; 1988 Feb; 34(2):213-8. PubMed ID: 2450214
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis problems in a case of minimal deviation adenocarcinoma of the cervix.
Simionescu C; Georgescu CV; Mărgăritescu C; Niculescu M
Rom J Morphol Embryol; 2006; 47(3):245-9. PubMed ID: 17308683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
